MedPath

Ayurveda Management Of Acute Excerbation Of Tamaka Shwasa(Bronchial Asthma) in Children

Phase 3
Not yet recruiting
Conditions
Acute bronchitis, unspecified. Ayurveda Condition: TAMAKASVASAH,
Registration Number
CTRI/2023/08/056084
Lead Sponsor
SDM College of ayurveda and hospital Hassan
Brief Summary

The objective of the study is to evaluate the effectiveness of sadyovamana in the management of tamaka shwasa in children. 30 subjects with tamaka shwasa will be administered vamana oushadhi during vegavastha and sadyovamana will be induced. The subjects will be assessed using suitable scoring parameters.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

Children aged 8 to 14 years irrespective of Gender and Socioeconomic status Children whose parents are willing to give consent Children fulfilling the Diagnostic Criteria Children fit for Sadyovamana.

Exclusion Criteria

Children with Severe complicated bronchial asthma needing intense care Children with life threatening asthma detected by presence of any of the following Cyanosis High grade fever Children with Congenital Heart Diseases Children unfit for Sadyovamana Children with known case of other chronic respiratory conditions like tuberculosis cystic fibrosis or other acute illness that would complicate current treatment and response for asthma.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in symptoms of bronchial asthma especially wheezing breathlessness cough sleeplessness7 days
Secondary Outcome Measures
NameTimeMethod
patient well being7 days

Trial Locations

Locations (1)

SDM College of ayurveda and hospital Hassan

🇮🇳

Hassan, KARNATAKA, India

SDM College of ayurveda and hospital Hassan
🇮🇳Hassan, KARNATAKA, India
Dr Mahanya N C
Principal investigator
9483442128
mahanya132@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.